Eric Haura

16PUBLICATIONS
143CO-AUTHORS
Molecular targetsCancer cell biologyGene and molecular therapyMedical biochemistry - proteins and peptides (incl. medical proteomics)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Jun 04, 2026
Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

|Dec 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK-driven lung cancer by concurrent integrin and MET signaling.

Qianqian Hu, Lily L Remsing Rix, Bina Desai

|Dec 12, 2025
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment.

Hayley D Ackerman, Vanessa Y Rubio, Andrew J Davis

|Oct 30, 2025
Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors.

Yaakov E Stern, Pompom Ghosh, John Peroza

|Oct 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer.

Hitendra S Solanki, Harshit Shah, Denis Imbody

Pageof 3

Frequent Collaborators

8 joint publications

John M Koomen

7 joint publications

Uwe Rix

5 joint publications

Andriy Marusyk

5 joint publications

Bina Desai